Trial now
USDCAD TECHS

Returning Lower

US TSYS SUMMARY

Risk-On Ahead July Employment Report

SOUTH AFRICA

New Finance Minister Godongwana Profile

AUDUSD TECHS

Bearish Focus

CHINA PRESS

China has reached "final stage" in approving the use of BioNTech's mRNA COVID-19 vaccine in cooption with Shanghai-based Fosun Pharma, the Global Times reported citing an interview with the German company's CEO Ugur Şahin. The developer is evaluating combining mRNA vaccines with inactivated and adenovirus vector jabs as booster shots to stabilize antibody levels against the coronavirus, Sahin was cited as saying. BioNTech is expected to be the first foreign-developed COVID-19 vaccine that China will import to pave the way for mixed shots in sequential inoculation, the newspaper said citing Shao Yiming, leading physician-scientist and immunologist serving at the Chinese Center for Disease Control and Prevention.